SWM
TMO icon

Salvus Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Salvus Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,112
Closed -$451K – 137
2025
Q2 		$451K Sell
1,112
-28
-2% -$11.7K 0.26% 88
2025
Q1 		$567K Buy
1,140
+40
+4% +$21.7K 0.36% 73
2024
Q4 		$572K Sell
1,100
-32
-3% -$17.6K 0.37% 71
2024
Q3 		$700K Buy
1,132
+38
+3% +$22.5K 0.43% 64
2024
Q2 		$605K Buy
1,094
+88
+9% +$50.4K 0.42% 65
2024
Q1 		$585K Buy
1,006
+397
+65% +$223K 0.4% 69
2023
Q4 		$323K Buy
609
+4
+0.7% +$1.94K 0.23% 89
2023
Q3 		$306K Buy
605
+59
+11% +$31.4K 0.24% 90
2023
Q2 		$285K Sell
546
-54
-9% -$29.1K 0.22% 91
2023
Q1 		$346K Buy
600
+40
+7% +$22.5K 0.28% 88
2022
Q4 		$308K Buy
+560
New +$297K 0.28% 79

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Salvus Wealth Management's TMO Position: Q3 2025 in Review

Salvus Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 1,112 shares — an estimated $451K sold.

Salvus Wealth Management first reported a position in TMO in Q4 2022 and held it in 11 quarters. The position peaked at $700K in Q3 2024. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Salvus Wealth Management reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Salvus Wealth Management sold 1,112 Thermo Fisher Scientific shares in Q3 2025, an estimated $451K.
  • Salvus Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 11 quarters.
  • Salvus Wealth Management's Thermo Fisher Scientific position peaked at $700K in Q3 2024.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Salvus Wealth Management's 13F filing for Q3 2025, filed 14 Oct 2025.